Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Argus Health
Healthtrust
Fish and Richardson
QuintilesIMS
Cantor Fitzgerald
Covington
Novartis
Accenture

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021319

« Back to Dashboard

NDA 021319 describes AVODART, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from three suppliers. Additional details are available on the AVODART profile page.

The generic ingredient in AVODART is dutasteride. There are seventeen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the dutasteride profile page.
Summary for 021319
Tradename:AVODART
Applicant:Glaxosmithkline
Ingredient:dutasteride
Patents:0
Therapeutic Class:Genitourinary Agents
Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 021319
Mechanism of Action5-alpha Reductase Inhibitors
Medical Subject Heading (MeSH) Categories for 021319
Suppliers and Packaging for NDA: 021319
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVODART dutasteride CAPSULE;ORAL 021319 NDA GlaxoSmithKline LLC 0173-0712 N 0173-0712-02
AVODART dutasteride CAPSULE;ORAL 021319 NDA GlaxoSmithKline LLC 0173-0712 N 0173-0712-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.5MG
Approval Date:Nov 20, 2001TE:ABRLD:Yes

Expired US Patents for NDA 021319

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline AVODART dutasteride CAPSULE;ORAL 021319-001 Nov 20, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline AVODART dutasteride CAPSULE;ORAL 021319-001 Nov 20, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline AVODART dutasteride CAPSULE;ORAL 021319-001 Nov 20, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Colorcon
Cerilliant
Express Scripts
Julphar
Queensland Health
Cipla
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot